August 3, 2005 |
A U.S. appeals court upheld most of a ruling that Research in Motion Ltd.'s BlackBerry e-mail pager infringed patents, delaying a judge's order to halt sales of the device in the U.S. The U.S. Court of Appeals for the Federal Circuit in Washington told U.S. District Judge James Spencer to rewrite his 2002 injunction to reflect decisions made on appeal. Research in Motion had agreed to pay $450 million to settle a dispute with NTP Inc., a closely held patent-licensing company.
April 9, 2005 |
A U.S. appeals court revived a lawsuit filed by Tyco International Ltd.'s Nellcor unit against Masimo Corp. over a patent for machines that measure the oxygen content in blood. The Court of Appeals for the Federal Circuit in Washington said a judge in Los Angeles who ruled against Nellcor had incorrectly interpreted Nellcor's patent. The lawsuit is one of several between the two companies, and the ruling gives Tyco a chance to try to win damages from closely held Masimo.
August 16, 2002 |
Teva Pharmaceutical Industries Ltd. may keep selling a low-cost version of Relafen after a U.S. appeals court upheld a ruling that invalidated a GlaxoSmithKline patent on the anti-inflammatory drug. Teva began selling a generic version of the drug, which generated $265 million a year for Middlesex, England-based Glaxo, in August 2001, after a federal judge invalidated the patent for the drug's active ingredient, nabumetone. The U.S.
October 28, 2006 |
The U.S. Supreme Court agreed to consider whether Microsoft Corp. should have to pay damages overseas for infringing a speech recognition software patent owned by AT&T Inc. The high court granted Microsoft's petition to review an appeals court ruling that held that AT&T could seek royalties based on the foreign manufacture and sale of infringing software products.
December 13, 2008 |
Bristol-Myers Squibb Co. and Sanofi-Aventis won an appeals court ruling Friday that will help them block generic competition to the blood thinner Plavix, the world's No. 2 selling-drug, in the U.S. until 2011. Bristol-Myers and Sanofi said that as a result of the ruling by a three-judge panel of the U.S. Court of Appeals for the Federal Circuit in Washington, they will seek reimbursement from Canadian drug maker Apotex Inc.
June 13, 2009 |
Dish Network Corp., which has won a temporary legal reprieve from halting its digital video recording service, is abusing the legal system with years of delays while it continues to infringe TiVo Inc.'s technology, an industry trade group said. The Assn. for Competitive Technology Inc., which represents smaller technology companies as well as Microsoft Corp., Oracle Corp. and EBay Inc., claims in a brief filed with the U.S. Court of Appeals for the Federal Circuit that Dish and EchoStar Communications Corp.
April 9, 2003 |
Schering-Plough Corp. argued before a U.S. appeals court that a judge erred in invalidating a patent that warded off generic competition to Claritin, once the company's top seller. The allergy drug, which accounted for almost a third of company revenue in 2001, is now sold as a nonprescription drug. Meanwhile, Wyeth is selling a competing generic equivalent, Alavert, and other rivals are expected to follow unless the U.S.
October 2, 2000 |
Amazon.com Inc.'s fight to bar rival Barnesandnoble.com Inc. from using a patented single-click online purchasing method goes before a federal appeals court, which will hear arguments today in a case that could shape the future of Internet business. The U.S. Court of Appeals for the Federal Circuit in Washington will decide whether to lift a preliminary injunction blocking Barnesandnoble.com from using technology that enables online purchases with one click of a computer mouse. Amazon.